Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Breast Health|August 21, 2018
Favorable Long-Term Outcome in Male Breast CancerEnver Özkurt, Mustafa Tükenmez, Ravza Yılmaz, et al.
Oncology Letters|July 11, 2014
Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapyUgur Gezer, Serkan Keskin, Abdullah Iğci, et al.
Breast Care (Basel, Switzerland)|January 2, 2023
Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival OutcomesEnver Özkurt, Selman Emiroğlu, Neslihan Cabioğlu, et al.
World Journal of Surgical Oncology|August 22, 2014
Comparison of the histopathology and prognosis of bilateral versus unilateral multifocal multicentric breast cancersHüseyin Kadioğlu, Serdar Özbaş, Alper Akcan, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|June 12, 2013
Laparoscopic surgery of the splenic artery and vein aneurysm with spontaneous arteriovenous fistulaUmut Barbaros, Ibrahim A Özemir, Nihat Aksakal, et al.
Balkan Medical Journal|September 30, 2017
Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-upEnver Özkurt, Mustafa Tükenmez, Erdem Güven, et al.
World Journal of Surgical Oncology|October 22, 2022
High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancerBaran Mollavelioglu, Esin Cetin Aktas, Neslihan Cabioglu, et al.
Neoplasma|June 7, 2021
Differential Expression of Novel Immune Checkpoint Receptors on Tumor Infiltrating Lymphocytes in Patients with Locally Advanced Breast Cancer after Neoadjuvant ChemotherapyAykhan Abbasov, Esin Aktas Cetin, Neslihan Cabioglu, et al.
European Journal of Breast Health|July 18, 2019
Our 20-Year Institutional Experience with Surgical Approach for Breast HamartomasZeliha Türkyılmaz, Tahacan Aydın, Ravza Yılmaz, et al.
World Journal of Surgical Oncology|September 3, 2021
Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapyGizem Oner, Semen Önder, Hüseyin Karatay, et al.
Pageof 3